Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'FLUVOXAMINE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 803 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Tournel, G; Houdret, N; Hedouin, V; Deveaux, M; Gosset, D; Lhermitte, M
      High-performance liquid chromatographic method to screen and quantitate seven selective serotonin reuptake inhibitors in human serum

      JOURNAL OF CHROMATOGRAPHY B
    2. Serretti, A; Zanardi, R; Rossini, D; Cusin, C; Lilli, R; Smeraldi, E
      Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity

      MOLECULAR PSYCHIATRY
    3. Hirose, S
      Restlessness related to SSRI withdrawal

      PSYCHIATRY AND CLINICAL NEUROSCIENCES
    4. Arnold, LM; Auchenbach, MB; McElroy, SL
      Psychogenic excoriation - Clinical features, proposed diagnostic criteria,epidemiology and approaches to treatment

      CNS DRUGS
    5. Durst, R; Katz, G; Teitelbaum, A; Zislin, J; Dannon, PN
      Kleptomania - Diagnosis and treatment options

      CNS DRUGS
    6. Ninan, PT; Berger, J
      Symptomatic and syndromal anxiety and depression

      DEPRESSION AND ANXIETY
    7. Meyers, BS; Klimstra, SA; Gabriele, M; Hamilton, M; Kakuma, T; Tirumalasetti, F; Alexopoulos, GS
      Continuation treatment of delusional depression in older adults

      AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
    8. Demers, JC; Malone, M
      Serotonin syndrome induced by fluvoxamine and mirtazapine

      ANNALS OF PHARMACOTHERAPY
    9. Anttila, SAK; Rasanen, I; Leinonen, EVJ
      Fluvoxamine augmentation increases serum mirtazapine concentrations three-to fourfold

      ANNALS OF PHARMACOTHERAPY
    10. Rojas, VM; Silva, R
      Palpebral twitching in a depressed adolescent on citalopram

      JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
    11. Garland, EJ; Baerg, EA
      Amotivational syndrome associated with selective serotonin reuptake inhibitors in children and adolescents

      JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
    12. Pace-Schott, EF; Gersh, T; Silvestri, R; Stickgold, R; Salzman, C; Hobson, JA
      SSRI Treatment suppresses dream recall frequency but increases subjective dream intensity in normal subjects

      JOURNAL OF SLEEP RESEARCH
    13. Hay, PJ; Bacaltchuk, J
      Extracts from "Clinical Evidence" - Bulimia nervosa

      BRITISH MEDICAL JOURNAL
    14. Phillips, KA; Crino, RD
      Body dysmorphic disorder

      CURRENT OPINION IN PSYCHIATRY
    15. Serretti, A; Zanardi, R; Cusin, C; Rossini, D; Lorenzi, C; Smeraldi, E
      Tryptophan hydroxylase gene associated with paroxetine antidepressant activity

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    16. Ohtani, H; Odagiri, Y; Sato, H; Sawada, Y; Iga, T
      A comparative pharmacodynamic study of the arrhythmogenicity of antidepressants, fluvoxamine and imipramine, in guinea pigs

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    17. Neylan, TC; Metzler, TJ; Schoenfeld, FB; Weiss, DS; Lenoci, M; Best, SR; Lipsey, TL; Marmar, CR
      Fluvoxamine and sleep disturbances in posttraumatic stress disorder

      JOURNAL OF TRAUMATIC STRESS
    18. Riddle, MA; Reeve, EA; Yaryura-Tobias, JA; Yang, HM; Claghorn, JL; Gaffney, G; Greist, JH; Holland, D; McConville, BJ; Pigott, T; Walkup, JT
      Fluvoxamine for children and adolescents with obsessive-compulsive disorder: A randomized, controlled, multicenter trial

      JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    19. Kakiuchi, T; Tsukada, H; Fukumoto, D; Nishiyama, S
      Effects of aging on serotonin transporter availability and its response tofluvoxamine in the living brain: PET study with [C-11](+)McN5652 and [C-11](-)McN5652 in conscious monkeys

      SYNAPSE
    20. Mundo, E; Rouillon, F; Figuera, ML; Stigler, M
      Fluvoxamine in obsessive-compulsive disorder: similar efficacy but superior tolerability in comparison with clomipramine

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    21. Toren, P; Eldar, S; Laor, N; Wolmer, L; Samuel, E; Weizman, R
      Fluvoxamine is ineffective in the treatment of enuresis in children and adolescents: an open-label pilot study

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    22. Skene, DJ; Papagiannidou, E; Hashemi, E; Snelling, J; Lewis, DFV; Fernandez, M; Ioannides, C
      Contribution of CYP1A2 in the hepatic metabolism of melatonin: studies with isolated microsomal preparations and liver slices

      JOURNAL OF PINEAL RESEARCH
    23. Starczewska, B
      Spectrophotometric determination of fluvoxamine maleate and fluoxetine hydrochloride

      JOURNAL OF TRACE AND MICROPROBE TECHNIQUES
    24. Francobandiera, G
      Olanzapine augmentation of serotonin uptake inhibitors in obsessive-compulsive disorder: An open study

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    25. Morrison, J; Remick, RA; Leung, M; Wrixon, KJ; Bebb, RA
      Galactorrhea induced by paroxetine

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    26. Furusho, J; Matsuzaki, K; Ichihashi, I; Satoh, H; Yamaguchi, K; Kumagai, K
      Alleviation of sleep disturbance and repetitive behavior by a selective serotonin re-uptake inhibitor in a boy with Asperger's syndrome

      BRAIN & DEVELOPMENT
    27. Ise, Y; Katayama, S; Hirano, M; Aoki, T; Narita, M; Suzuki, T
      Effects of fluvoxamine on morphine-induced inhibition of gastrointestinal transit, antinociception and hyperlocomotion in mice

      NEUROSCIENCE LETTERS
    28. Mauri, MC; Boscati, L; Volonteri, LS; Scalvini, ME; Steinhilber, CPC; Laini, V; Zamberlan, F
      Predictive value of amino acids in the treatment of major depression with fluvoxamine

      NEUROPSYCHOBIOLOGY
    29. Kohn, Y; Weizman, A; Apter, A
      Aggravation of food-related behavior in an adolescent with Prader-Willi syndrome treated with fluvoxamine amd fluoxetine

      INTERNATIONAL JOURNAL OF EATING DISORDERS
    30. Erzegovesi, S; Cavallini, MC; Cavedini, P; Diaferia, G; Locatelli, M; Bellodi, L
      Clinical predictors of drug response in obsessive-compulsive disorder

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    31. Moller, SE; Larsen, F; Khan, AZ; Rolan, PE
      Lack of effect of citalopram on the steady-state pharmacokinetics of carbamazepine in healthy male subjects

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    32. Gilaberte, I; Montejo, AL; de la Gandara, J; Perez-Sola, V; Bernardo, M; Massana, J; Martin-Santos, R; Santiso, A; Noguera, R; Casais, L; Perez-Camo, V; Arias, M; Judge, R
      Fluoxetine in the prevention of depressive recurrences: A double-blind study

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    33. Bertani, A; Caldirola, D; Bussi, R; Bellodi, L; Perna, G
      The 35% CO2 hyperreactivity and clinical symptomatology in patients with panic disorder after week of treatment with citalopram: An open study

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    34. Waldinger, MD; Zwinderman, AH; Olivier, B
      Antidepressants and ejaculation: A double-blind, randomized, placebo-controlled, fixed-dose study with paroxetine, sertraline, and nefazodone

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    35. Romano, S; Goodman, W; Tamura, R; Gonzales, J
      Long-term treatment of obsessive-compulsive disorder after an acute response: A comparison of fluoxetine versus placebo

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    36. Baede-van Dijk, PA; Hugen, PWH; Verweij-van Wissen, CPWGM; Koopmans, PP; Burger, DM; Hekster, YA
      Analysis of variation in plasma concentrations of nelfinavir and its active metabolite M8 in HIV-positive patients

      AIDS
    37. Meythaler, JM; Depalma, L; Devivo, MJ; Guin-Renfroe, S; Novack, TA
      Sertraline to improve arousal and alertness in severe traumatic brain injury secondary to motor vehicle crashes

      BRAIN INJURY
    38. Stein, DJ; Montgomery, SA; Kasper, S; Tanghoj, P
      Predictors of response to pharmacotherapy with citalopram in obsessive-compulsive disorder

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    39. Boshuisen, ML; Slaap, BR; Vester-Blokland, ED; den Boer, JA
      The effect of mirtazapine in panic disorder: an open label pilot study with a single-blind placebo run-in period

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    40. Marazziti, D; Dell'Osso, L; Gemignani, A; Ciapparelli, A; Presta, S; Di Nasso, E; Pfanner, C; Cassano, GB
      Citalopram in refractory obsessive-compulsive disorder: an open study

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    41. Clere, G
      Antidepressant efficacy and tolerability of milnacipran, a dual serotonin and noradrenaline reuptake inhibitor: a comparison with fluvoxamine

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    42. Montgomery, SA; Kasper, S; Stein, DJ; Hedegaard, KB; Lemming, OM
      Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    43. Perna, G; Bertani, A; Caldirola, D; Smeraldi, E; Bellodi, L
      A comparison of citalopram and paroxetine in the treatment of panic disorder: A randomized, single-blind study

      PHARMACOPSYCHIATRY
    44. Asnis, GM; Hameedi, FA; Goddard, AW; Potkin, SG; Black, D; Jameel, M; Desagani, K; Woods, SW
      Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients

      PSYCHIATRY RESEARCH
    45. Poyurovsky, M; Hramenkov, S; Isakov, V; Rauchverger, B; Modai, I; Schneidman, M; Fuchs, C; Weizman, A
      Obsessive-compulsive disorder in hospitalized patients with chronic schizophrenia

      PSYCHIATRY RESEARCH
    46. Spina, E; Avenoso, A; Scordo, MG; Ancione, M; Madia, A; Levita, A
      No effect of reboxetine on plasma concentrations of clozapine, risperidone, and their active metabolites

      THERAPEUTIC DRUG MONITORING
    47. Weigmann, H; Gerek, S; Zeisig, A; Muller, M; Hartter, S; Hiemke, C
      Fluvoxamine but not sertraline inhibits the metabolism of olanzapine: Evidence from a therapeutic drug monitoring service

      THERAPEUTIC DRUG MONITORING
    48. de la Torre, BR; Dreher, J; Malevany, L; Bagli, M; Kolbinger, M; Omran, H; Luderitz, B; Rao, ML
      Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients

      THERAPEUTIC DRUG MONITORING
    49. Spina, E; Avenoso, A; Facciola, G; Scordo, MG; Ancione, M; Madia, A
      Plasma concentrations of risperidone and 9-hydroxyrisperidone during combined treatment with paroxetine

      THERAPEUTIC DRUG MONITORING
    50. Mamiya, K; Kojima, K; Yukawa, E; Higuchi, S; Ieiri, I; Ninomiya, H; Tashiro, N
      Phenytoin intoxication induced by fluvoxamine

      THERAPEUTIC DRUG MONITORING
    51. Phillips, KA; Albertini, RS; Siniscalchi, JM; Khan, A; Robinson, M
      Effectiveness of pharmacotherapy for body dysmorphic disorder: A chart-review study

      JOURNAL OF CLINICAL PSYCHIATRY
    52. Mulsant, BH; Sweet, RA; Rosen, J; Pollock, BG; Zubenko, GS; Flynn, T; Begley, AE; Mazumdar, S; Reynolds, CF
      A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression inlate life

      JOURNAL OF CLINICAL PSYCHIATRY
    53. Alonso, P; Menchon, JM; Pifarre, J; Mataix-Cols, D; Torres, L; Salgado, P; Vallejo, J
      Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy

      JOURNAL OF CLINICAL PSYCHIATRY
    54. Weihs, KL; Batey, SR; Houser, TL; Donahue, RMJ; Ascher, JA
      Type II error and antidepressants - Dr. Weihs and colleagues reply

      JOURNAL OF CLINICAL PSYCHIATRY
    55. Saxena, S; Winograd, A; Dunkin, JJ; Maidment, K; Rosen, R; Vapnik, T; Tarlow, G; Bystritsky, A
      A retrospective review of clinical characteristics and treatment response in body dysmorphic disorder versus obsessive-compulsive disorder

      JOURNAL OF CLINICAL PSYCHIATRY
    56. Montejo, AL; Llorca, G; Izquierdo, JA; Rico-Villademoros, F
      Incidence of sexual dysfunction associated with antidepressant agents: A prospective multicenter study of 1022 outpatients

      JOURNAL OF CLINICAL PSYCHIATRY
    57. Coleman, CC; King, BR; Bolden-Watson, C; Book, MJ; Segraves, RT; Richard, N; Ascher, J; Batey, S; Jamerson, B; Metz, A
      A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine

      CLINICAL THERAPEUTICS
    58. Dewa, CS; Hoch, JS; Goering, P
      Using forecasting models to estimate the effects of changes in the composition of claims for selective serotonin reuptake inhibitors on expenditures

      CLINICAL THERAPEUTICS
    59. Michelson, D; Schmidt, M; Lee, J; Tepner, R
      Changes in sexual function during acute and six-month fluoxetine therapy: A prospective assessment

      JOURNAL OF SEX & MARITAL THERAPY
    60. Amchin, J; Ereshefsky, L; Zarycranski, W; Taylor, K; Albano, D; Klockowski, PM
      Effect of venlafaxine versus fluoxetine on metabolism of dextromethorphan,a CYP2D6 probe

      JOURNAL OF CLINICAL PHARMACOLOGY
    61. Ricca, V; Mannucci, E; Mezzani, B; Moretti, S; Di Bernardo, M; Bertelli, M; Rotella, C; Faravelli, C
      Fluoxetine and fluvoxamine combined with individual cognitive-behaviour therapy in binge eating disorder: A one-year follow-up study

      PSYCHOTHERAPY AND PSYCHOSOMATICS
    62. Keuthen, NJ; Deckersbach, T; Wilhelm, S; Engelhard, I; Forker, A; O'Sullivan, RL; Jenike, MA; Baer, L
      The Skin Picking Impact Scale (SPIS) - Scale development and psychometric analyses

      PSYCHOSOMATICS
    63. Takamori, K; Yoshida, S; Okuyama, S
      Availability of learned helplessness test as a model of depression compared to a forced swimming test in rats

      PHARMACOLOGY
    64. Sy, SKB; Tang, BK; Pastrakuljic, A; Roberts, EA; Kalow, W
      Detailed characterization of experimentally derived human hepatic CYP1A1 activity and expression using differential inhibition of ethoxyresorufin O-deethylation by fluvoxamine

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    65. Kivisto, KT; Wang, JS; Backman, JT; Nyman, L; Taavitsainen, P; Anttila, M; Neuvonen, PJ
      Selegiline pharmacokinetics are unaffected by the CYP3A4 inhibitor itraconazole

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    66. Facciola, G; Hidestrand, M; von Bahr, C; Tybring, G
      Cytochrome P-450 isoforms involved in melatonin metabolism in human liver microsomes

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    67. Gourevitch, MN
      Interactions between HIV-related medications and methadone: An overview

      MOUNT SINAI JOURNAL OF MEDICINE
    68. Jenike, MA
      An update on obsessive-compulsive disorder

      BULLETIN OF THE MENNINGER CLINIC
    69. Seo, KK; Kim, SC; Lee, MY
      Comparison of peripheral inhibitory effects of clomipramine with selectiveserotonin re-uptake inhibitors on contraction of vas deferens: In vitro and in vivo studies

      JOURNAL OF UROLOGY
    70. Daniel, WA; Syrek, M; Haduch, A; Wojcikowski, J
      The effect of selective serotonin reuptake inhibitors (SSRIs) on the pharmacokinetics and metabolism of perazine in the rat

      JOURNAL OF PHARMACY AND PHARMACOLOGY
    71. Fujishiro, J; Imanishi, T; Baba, J; Kosaka, K
      Comparison of noradrenergic and serotonergic antidepressants in reducing immobility time in the tail suspension test

      JAPANESE JOURNAL OF PHARMACOLOGY
    72. Li, XB; Inoue, T; Hashimoto, S; Koyama, T
      Effect of chronic administration of flesinoxan and fluvoxamine on freezingbehavior induced by conditioned fear

      EUROPEAN JOURNAL OF PHARMACOLOGY
    73. Jokinen, MJ; Olkkola, KT; Ahonen, J; Neuvonen, PJ
      Effect of rifampin and tobacco smoking on the pharmacokinetics of ropivacaine

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    74. Hartter, S; Ursing, C; Morita, S; Tybring, G; von Bahr, C; Christensen, M; Rojdmark, S; Bertilsson, L
      Orally given melatonin may serve as a probe drug for cytochrome P450 1A2 activity in vivo: A pilot study

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    75. Weiss, JL; Weiss, KL; Benecke, SM
      Serotonin mediated cluster headache, trigeminal neuralgia, glossopharyngeal neuralgia, and superior laryngeal neuralgia with SAD chronicity

      CHILD PSYCHIATRY & HUMAN DEVELOPMENT
    76. Sanchez, V; Camarero, J; Esteban, B; Peter, MJ; Green, AR; Colado, MI
      The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain

      BRITISH JOURNAL OF PHARMACOLOGY
    77. Zanardi, R; Serretti, A; Rossini, D; Franchini, L; Cusin, C; Lattuada, E; Dotoli, D; Smeraldi, E
      Factors affecting fluvoxamine antidepressant activity: Influence of pindolol and 5-HTTLPR in delusional and nondelusional depression

      BIOLOGICAL PSYCHIATRY
    78. Strauss, WL; Dager, SR
      Magnetization transfer of fluoxetine in the human brain using fluorine magnetic resonance spectroscopy

      BIOLOGICAL PSYCHIATRY
    79. Kim, SW; Grant, JE; Adson, DE; Shin, YC
      Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling

      BIOLOGICAL PSYCHIATRY
    80. Mundo, E; Walker, M; Cate, T; Macciardi, F; Kennedy, JL
      The role of serotonin transporter protein gene in antidepressant-induced mania in bipolar disorder - Preliminary findings

      ARCHIVES OF GENERAL PSYCHIATRY
    81. Van Ameringen, MA; Lane, RM; Walker, JR; Bowen, RC; Chokka, PR; Goldner, EM; Johnston, DG; Lavallee, YJ; Nandy, S; Pecknold, JC; Hadrava, V; Swinson, RP
      Sertraline treatment of generalized social phobia: A 20-week, double-blind, placebo-controlled study

      AMERICAN JOURNAL OF PSYCHIATRY
    82. Otto, MW; Tuby, KS; Gould, RA; McLean, RYS; Pollack, MH
      An effect-size analysis of the relative efficacy and tolerability of serotonin selective reuptake inhibitors for panic disorder

      AMERICAN JOURNAL OF PSYCHIATRY
    83. Hori, H; Yoshimura, R; Nakamura, J
      Increased libido in a woman treated with fluvoxamine: a case report

      ACTA PSYCHIATRICA SCANDINAVICA
    84. Stein, DJ; Stein, MB; Goodwin, W; Kumar, R; Hunter, B
      The selective serotonin reuptake in more generalized and in less inhibitorparoxetine is effective generalized social anxiety disorder

      PSYCHOPHARMACOLOGY
    85. Silva, M; Hetem, LAB; Guimaraes, FS; Graeff, FG
      Opposite effects of nefazodone in two human models of anxiety

      PSYCHOPHARMACOLOGY
    86. Hartter, S; Weigmann, H; Hiemke, C
      Automated determination of reboxetine by high-performance liquid chromatography with column-switching and ultraviolet detection

      JOURNAL OF CHROMATOGRAPHY B
    87. Fountoulakis, KN; Tsolaki, M; Kazis, A
      Target symptoms for fluvoxamine in old age depression

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    88. Furusho, J; Kubagawa, T; Saitoh, N; Matsuzaki, K; Yamakawa, H; Iikura, Y
      The first Japanese pediatric case of obsessive-compulsive disorder who responded to a selective serotonin re-uptake inhibitor

      PEDIATRICS INTERNATIONAL
    89. Elmali, F; Alpdogan, G; Sungur, S; Aycan, S
      Polarographic determination of fluvoxamine maleate in tablets

      TURKISH JOURNAL OF CHEMISTRY
    90. Black, K; Shea, C; Dursun, S; Kutcher, S
      Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    91. Mavissakalian, MR; Schmier, JK; Flynn, JA; Revicki, DA
      Cost effectiveness of acute imipramine therapy versus two imipramine maintenance treatment regimens for panic disorder

      PHARMACOECONOMICS
    92. Ereshefsky, L; Dugan, D
      Review of the pharmacokinetics, pharmacogenetics, and drug interaction potential of antidepressants: Focus on venlafaxine

      DEPRESSION AND ANXIETY
    93. Reichman, WE
      Alzheimer's disease: Clinical treatment options

      AMERICAN JOURNAL OF MANAGED CARE
    94. Carpenter, LL; Price, LH
      Psychotic depression: What is it and how should we treat it?

      HARVARD REVIEW OF PSYCHIATRY
    95. Cyr, M; Farrar, MK
      Treatment for posttraumatic stress disorder

      ANNALS OF PHARMACOTHERAPY
    96. Kim, KY; Craig, JM; Hawley, JM
      Seizure possibly associated with fluvoxamine

      ANNALS OF PHARMACOTHERAPY
    97. Hamilton, SP; Nunes, EV; Janal, M; Weber, L
      The effect of sertraline on methadone plasma levels in methadone-maintenance patients

      AMERICAN JOURNAL ON ADDICTIONS
    98. Nevado, JJB; Flores, JR; Penalvo, GC
      Voltammetric behavior of fluvoxamine using square-wave and adsorptive stripping square-wave techniques. Determination in pharmaceutical products

      ELECTROANALYSIS
    99. Thomsen, PH
      Obsessive-compulsive disorder: pharmacological treatment

      EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
    100. Cowen, PJ
      Psychopharmacology of 5-HT1A receptors

      NUCLEAR MEDICINE AND BIOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/02/20 alle ore 16:30:50